U.S. farm, consumer groups aim to block Monsanto bid for Syngenta Aug. 4- Several U.S. farm and consumer groups are working on strategies to derail a proposed tie-up of Monsanto Co and agricultural seeds and chemicals rival Syngenta AG, saying a combination of the market leaders would spell fewer and higher-priced products. Coalitions of opponents are being formed and market analyzes being done, moves that underscore the...
| By: Carey Gillam
Uneven performances in Trump-less Republican forum Republican candidates found themselves Trump-less in a forum Monday night, delivering strikingly uneven performances, The New York Times reports.
Source: The New York Times
| By: Jeremy W. Peters and Micahel Barbaro
UPDATE 2-Drugmaker Shire bids $30 bln for Baxter spin-off Baxalta LONDON, Aug 4- Drugmaker Shire said on Tuesday it was seeking to buy Baxalta, a company spun-off by Baxter International last month, for $30 billion to forge the leading global specialist in rare diseases. Shire said its unsolicited offer of 0.1687 Shire American depositary receipts per share valued each Baxalta share at $45.23. Shares in Baxalta jumped 19...
| By: Paul Sandle
UPDATE 1-Shire goes public with proposed $30 bln Baxalta tie-up LONDON, Aug 4- London- listed group Shire said it was seeking to buy Baxalta in a $30 billion all-share deal, going public with its bid to create a global specialist in rare diseases after the U.S. firm spurned its initial approach. Shire said its unsolicited offer valued each Baxalta share at $45.23. The share offer, which marks a premium of 36 percent over Baxalta's...
Shire proposes $30 bln all-share tie-up with Baxalta LONDON, Aug 4- London- listed pharmaceutical group Shire said it was seeking to buy U.S. firm Baxalta in a $30 billion all-share deal to create a global specialist in medicines treating rare diseases with sales of $20 billion by 2020.. Shire went public with its proposal on Tuesday after Baxalta rejected the approach. Shire said it had offered to pay 0.1687 Shire...
Aetna tops 2Q profit forecasts Aetna's second-quarter earnings jumped 33 percent and the health insurer raised its 2015 forecast again after receiving a boost from a government business it plans to feed with a $35 billion acquisition. Aetna said Thursday that higher underwriting margins or improved profitability helped balance a jump in operating costs. For the second quarter, Aetna...
Source: The Associated Press
UPDATE 1-Italy's Exor wins battle to buy PartnerRe for $6.9 bln MILAN, Aug 3- Investment group Exor, which controls carmaker Fiat Chrysler, said on Monday it had signed a deal to buy PartnerRe for $6.9 billion, ending a prolonged battle for the reinsurer against a rival bid from Axis Capital. The agreement marks a U-turn for PartnerRe, which in January had agreed a merger with Axis and repeatedly spurned approaches from Exor,...
| By: Agnieszka Flak
Why this analyst is 'negative' traditional media stocks Television advertising - its life blood - is struggling, says Rich Greenfield, BTIG media & tech analyst, providing his outlook on the media sector as the group prepares to unleash a slew of earnings this week.